|
Video: What is a Stock Split?
|
|
Frequency Therapeutics is a clinical-stage biotechnology company focused on developing therapeutics to activate a person's innate regenerative potential to restore function. Co. develops FX-322 to treat an underlying cause of sensorineural hearing loss, which is the loss of hair cells. Co.'s proprietary approach, Progenitor Cell Activation, uses small molecules to activate progenitor cells within the body to create functional tissue. These progenitor cells, which are closely related to stem cells, are already resident in the targeted location in the body and programmed to develop and differentiate into specific cell types within an organ. According to our KRRO split history records, Korro Bio has had 1 split. | |
|
Korro Bio (KRRO) has 1 split in our KRRO split history database. The split for KRRO took place on November 06, 2023. This was a 1 for 50 reverse split, meaning for each 50 shares of KRRO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 20 share position following the split.
When a company such as Korro Bio conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the KRRO split history from start to finish, an original position size of 1000 shares would have turned into 20 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Korro Bio shares, starting with a $10,000 purchase of KRRO, presented on a split-history-adjusted basis factoring in the complete KRRO split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
10/04/2019 |
|
End date: |
04/30/2024 |
|
Start price/share: |
$674.50 |
|
End price/share: |
$56.79 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-91.58% |
|
Average Annual Total Return: |
-41.78% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$841.64 |
|
Years: |
4.58 |
|
|
|
Date |
Ratio |
11/06/2023 | 1 for 50 |
|
|